ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,539,000 | +3.1% | 1,100,000 | 0.0% | 1.58% | -13.0% |
| Q2 2023 | $21,857,000 | +16.0% | 1,100,000 | 0.0% | 1.81% | -18.1% |
| Q1 2023 | $18,843,000 | -12.5% | 1,100,000 | 0.0% | 2.21% | -1.7% |
| Q4 2022 | $21,527,000 | +34.9% | 1,100,000 | +10.0% | 2.25% | +47.5% |
| Q3 2022 | $15,953,000 | +15.9% | 999,588 | -0.0% | 1.53% | +14.8% |
| Q2 2022 | $13,760,000 | -13.2% | 1,000,000 | 0.0% | 1.33% | -13.0% |
| Q1 2022 | $15,860,000 | -27.3% | 1,000,000 | 0.0% | 1.53% | -22.9% |
| Q4 2021 | $21,830,000 | -27.0% | 1,000,000 | 0.0% | 1.98% | +39.7% |
| Q3 2021 | $29,890,000 | -32.5% | 1,000,000 | 0.0% | 1.42% | -38.7% |
| Q2 2021 | $44,290,000 | – | 1,000,000 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |